Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples